Edesa Biotech, Inc. (EDSA)
NASDAQ: EDSA · Real-Time Price · USD
1.350
-0.030 (-2.17%)
Jan 28, 2026, 3:08 PM EST - Market open
Edesa Biotech Market Cap
Edesa Biotech has a market cap or net worth of $11.25 million as of January 28, 2026. Its market cap has increased by 82.27% in one year.
Market Cap
11.25M
Enterprise Value
875.18K
1-Year Change
82.27%
Ranking
Category
Stock Price
$1.35
Market Cap Chart
Since June 10, 2019, Edesa Biotech's market cap has decreased from $37.12M to $11.25M, a decrease of -69.69%. That is a compound annual growth rate of -16.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 26, 2026 | 12.00M | 1.41% |
| Dec 31, 2025 | 11.83M | 103.14% |
| Dec 31, 2024 | 5.83M | -59.72% |
| Dec 29, 2023 | 14.46M | -65.40% |
| Dec 30, 2022 | 41.80M | -45.08% |
| Dec 31, 2021 | 76.11M | 70.18% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jun 10, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NewcelX | 12.82M |
| Akari Therapeutics, | 12.82M |
| Sensei Biotherapeutics | 12.68M |
| Imunon | 12.50M |
| NuCana | 12.32M |
| Longeveron | 11.90M |
| Curis | 11.68M |
| Phio Pharmaceuticals | 10.98M |